Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000950
Filing Date
2025-01-06
Accepted
2025-01-06 21:52:45
Documents
2
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01072025_020140.html 4  
1 form4-01072025_020140.xml 4 16513
2 ex24-01072025_020141.htm EX-24 6603
  Complete submission text file 0001415889-25-000950.txt   24561
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW STREET, SUITE A-100 DURHAM NC 27701
Business Address
Heery Christopher (Reporting) CIK: 0001789632 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 25513328